[Sneddon-Wilkinson disease. Four cases report]. 2004

F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
Service de dermatologie, CHU Purpan, Toulouse, France.

BACKGROUND We report four cases of subcorneal pustular dermatosis or Sneddon-Wilkinson disease. Clinical and histological lesions and immunofluorescence data were presented. This disease is classified among neutrophilic dermatitis. METHODS All of four patients presented with clinical and histological lesions compatible with the diagnosis of Sneddon-Wilkinson disease. Indeed, direct and indirect immuno-testing were negative. We noted an association with a benign IgA monoclonal gammapathy in one case and with a seronegative polyarthritis in one other case. Three patients correctly responded to dapsone. One of them after transient improvement was resistant to dapsone and then dramatically responded to etretinate. CONCLUSIONS Subcorneal pustular dermatosis is a chronic disease, rarely described in literature. It's a pustular eruption, involving the trunck, axillae and inguinal holds. It's often associated with monoclonal gammapathy, particulary IgA. Its nosological situation is still contested, especially with IgA pemphigus sharing with it the association with IgA monoclonal gammapathy and the same efficacy of dapsone. We discuss relationships between both diseases.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007641 Keratolytic Agents Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. Desquamating Agents,Skin-Peeling Agents,Agents, Desquamating,Agents, Keratolytic,Agents, Skin-Peeling,Skin Peeling Agents
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010265 Paraproteinemias A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin. Gammapathy, Monoclonal,Gammopathy, Monoclonal,Monoclonal Gammopathies,Paraimmunoglobulinemia,Paraimmunoglobulinemias,Paraproteinemia,Plasma Cell Dyscrasias,Monoclonal Gammapathies,Monoclonal Gammopathy,Cell Dyscrasia, Plasma,Dyscrasia, Plasma Cell,Monoclonal Gammapathy,Plasma Cell Dyscrasia
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D005050 Etretinate An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic. B10-9359,Ethyl Etrinoate,Ro 10-9359,Ro-10-9359,Tigason,Tigazon,B10 9359,B109359,Etrinoate, Ethyl,Ro 10 9359,Ro 109359,Ro109359
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
June 1972, Vestnik dermatologii i venerologii,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
January 2022, The Pan African medical journal,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
April 2009, Clinical and experimental dermatology,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
January 1996, Indian journal of dermatology, venereology and leprology,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
January 1966, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
May 1962, Archives belges de dermatologie et de syphiligraphie,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
January 1975, Przeglad dermatologiczny,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
January 1995, Indian journal of dermatology, venereology and leprology,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
July 1967, Lyon medical,
F Launay, and B Albès, and P Bayle, and M Carrière, and L Lamant, and J Bazex
January 1961, Przeglad dermatologiczny,
Copied contents to your clipboard!